LE MOLI, ROSARIO
 Distribuzione geografica
Continente #
NA - Nord America 1.558
AS - Asia 893
EU - Europa 454
SA - Sud America 325
AF - Africa 27
Totale 3.257
Nazione #
US - Stati Uniti d'America 1.517
SG - Singapore 380
BR - Brasile 271
HK - Hong Kong 185
CN - Cina 125
IE - Irlanda 115
IT - Italia 112
VN - Vietnam 81
DE - Germania 50
FR - Francia 44
GB - Regno Unito 32
AR - Argentina 22
IN - India 21
PL - Polonia 20
CA - Canada 18
BD - Bangladesh 16
MX - Messico 16
NL - Olanda 16
TR - Turchia 14
EC - Ecuador 12
IQ - Iraq 11
MA - Marocco 10
FI - Finlandia 9
ID - Indonesia 9
ES - Italia 8
JP - Giappone 8
SE - Svezia 8
ZA - Sudafrica 7
AT - Austria 6
CO - Colombia 6
UZ - Uzbekistan 6
MY - Malesia 5
NP - Nepal 5
RU - Federazione Russa 5
SA - Arabia Saudita 5
UA - Ucraina 5
CL - Cile 4
LT - Lituania 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
EE - Estonia 3
JO - Giordania 3
PK - Pakistan 3
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
LV - Lettonia 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.257
Città #
Dallas 596
Singapore 222
Hong Kong 184
San Jose 173
Ashburn 145
Dublin 113
The Dalles 78
Chicago 62
Santa Clara 59
Beijing 58
Boardman 57
Ho Chi Minh City 31
Assago 22
Los Angeles 20
São Paulo 19
Hanoi 17
Catania 16
Warsaw 15
Council Bluffs 14
Hillsboro 14
New York 12
Düsseldorf 11
Naples 11
Mexico City 10
Munich 10
Rio de Janeiro 10
Frankfurt am Main 9
Helsinki 9
Istanbul 9
Nuremberg 9
Reston 8
Tokyo 8
Belo Horizonte 7
Baghdad 6
London 6
Milan 6
Orem 6
Salvador 6
Atlanta 5
Brasília 5
Brooklyn 5
Casablanca 5
Guarulhos 5
Lauterbourg 5
Paris 5
Porto Alegre 5
Seattle 5
Tashkent 5
Chennai 4
Johannesburg 4
Manchester 4
Montreal 4
Mumbai 4
Palermo 4
Phoenix 4
Quito 4
Ribeirão Preto 4
Stockholm 4
Wroclaw 4
Bắc Ninh 3
Campinas 3
Curitiba 3
Da Nang 3
Guayaquil 3
Hải Dương 3
Imperatriz 3
Itaquaquecetuba 3
Lima 3
Limburg an der Lahn 3
Mascalucia 3
Messina 3
New Delhi 3
Ottawa 3
Poplar 3
Porto 3
Portsmouth 3
Putian 3
Riyadh 3
Rome 3
San Francisco 3
Sobral 3
Tallinn 3
Toronto 3
Amman 2
Angeles City 2
Ankara 2
Asunción 2
Baku 2
Balneário Camboriú 2
Barbacena 2
Bauru 2
Bishkek 2
Bismarck 2
Biên Hòa 2
Cao Lanh 2
Cape Town 2
Charlotte 2
Chongqing 2
Cotia 2
Cremona 2
Totale 2.268
Nome #
A marker of inflammatory state and the clinical outcome of active go to parenteral glucocorticoids 84
Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension 84
A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy 79
Very low serum IGF-1 levels are associated with vertebral fractures in adult males with beta-thalassemia major 76
Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence 75
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration 73
Early detection of suspicious lymph nodes in differentiated thyroid cancer 73
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 73
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves’ Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 72
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 70
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 68
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy 67
Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem 65
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 65
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 65
A novel methodology for epidemic risk assessment of COVID-19 outbreak 64
Determinants of Liver Damage Associated with Intravenous Methylprednisolone Pulse Therapy in Graves' Ophthalmopathy 64
A Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: Clinical and Pathologic Features and Outcomes of 34 Consecutive Cases 64
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling 64
Determinants of longterm outcome of radioiodine therapy of sporadic non- toxic goitre 63
Cholesterol and Graves’ Orbitopathy (GO): ‘A new decision-making algorithm based on baseline low density lipoprotein cholesterol (LDLc) and early GO clinical response to parenteral corticosteroids’ 62
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 62
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 61
Orbital metastasis from thyroid cancer: a case report and review of the literature 61
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 59
Papillary thyroid carcinoma: ≤ 10 mm does not always mean pN0. A multicentric real-world study 58
Recent insights into the pathogenesis of autoimmune hypophysitis 58
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 55
Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update 54
Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study 53
Establishment of reference values for endocrine tests II: Hyperprolactinemia 52
The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy 51
Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients 51
Diabetic neuropathy: Prevalence, concordance between clinical and electrophysiological testing and impact of risk factors 51
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: the role of dose and route of administration 50
Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment|Effetti dell'octreotide sui livelli glicemici in diabetici insulino-dipendenti mal compensati con trattamento insulinico 49
Effects of Dietary Habits on Markers of Oxidative Stress in Subjects with Hashimoto’s Thyroiditis: Comparison Between the Mediterranean Diet and a Gluten-Free Diet 48
Different effects of octreotide by continuous night infusion at increasing rate or by evening injections at different times on morning hyperglycemia and growth hormone levels in insulin-dependent diabetic patients 48
Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy 46
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients 45
Severe Graves' Ophthalmopathy After Percutaneous Ethanol Injection in a Nontoxic Thyroid Nodule 45
Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans 45
The monocyte/HDLc ratio and LDLc are two independent predictors of the response of Graves’ ophthalmopathy patients to parenteral glucocorticoids 44
Graves’ Orbitopathy: Extraocular Muscle/Total Orbit Area Ratio is Positively Related to the Clinical Activity Score 44
TKIS for advanced thyroid cancer increase tsh levels in thyroidectomized patients: A meta-analysis 44
The contemporary assumption of methimazole and acetominophen caused drug-induced liver injury in a female patient with Graves' disease and ophthalmopathy: A case report 44
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy 43
Postoperative basal serum thyroglobulin and need for radioiodine in patients with low to intermediate-risk papillary thyroid cancer 43
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids 42
Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans 42
Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function 40
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study 39
Insulin Analogs and Cancer 38
Lack of pharmacological effect of subcutaneous octreotide in an insulin-dependent diabetic patient: Reversal after mixing with aprotinin 37
Temporal trends in the clinical presentation of graves' ophthalmopathy: a single - centre retrospective study 37
Low-intermediate risk thyroid cancer: no benefit of postsurgical iodine? 36
Mediterranean diet, selenium and Graves’ ophthalmopathy: a prospective, randomized, single-center study 35
Rebound effect in hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism and hormonal replacement therapies 35
Evaluation of endocrine tests. A: The TRH test in patients with hyperprolactinaemia 34
Temporal trends in the clinical presentation of Graves’ orbitopathy: a single–center retrospective study 32
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review 31
Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients 28
Minimal or Absent Tumor Desmoplasia Predicts Lower Recurrence Risk in Papillary Thyroid Carcinoma 23
Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiography 18
Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss 18
Totale 3.399
Categoria #
all - tutte 15.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 6 0 0 3 0 0 0 0
2022/20236 2 0 0 0 0 1 0 0 0 2 1 0
2023/202412 0 1 0 0 1 0 3 1 0 0 4 2
2024/20251.205 98 46 69 31 128 230 103 58 110 123 116 93
2025/20262.167 143 423 416 225 83 82 243 225 174 153 0 0
Totale 3.399